TechnoPhage, SA - From science to innovative biopharmaceuticals
TechnoPhage is currently looking for a Head of Neuroscience/Ophthalmology (PhD) with a strong scientific background to lead a team dedicated to characterize and understand the function of therapeutics against a large range of targets. Click here to know more.
Technophage S.A., in collaboration with a team led by Leonor Saúde, Principal Investigator of the Instituto de Medicina Molecular João Lobo Antunes (iMM), developed a simple, fast and efficient zebrafish screening platform to discover and select new therapeutics for spinal cord injuries. This study that was published today in the Scientific Reports journal…
The United States Patent and Trademark Office recently issued a notice of allowance for US patent application number 15/568,655 covering Technophage's TZ-113 project. TZ-113 is a repurposing project for Parkinson's patients targeting levodopa induced diskynesia during OFF periods. US15/568,655 is the most recent addition to Technophage's list of allowed patents. Technophage patent portfolio…
TechnoPhage's CEO Miguel Garcia will attend the 11th Annual International Partnering Conference ChinaBio® Partnering Forum on May 8-9 in Shangai, China. If you wish to meet us at the conference feel free to contact us to This email address is being protected from spambots. You need JavaScript enabled to view it. to schedule a meeting.

2019 events

Phage Futures Europe
Brussels, Belgium, September 25-26, 2019